Showing results (111-120 of 8,520) with videos related to
Sort By:
Pageof 852
Alimentary Pharmacology & Therapeutics|December 1, 1989
Prolonged inhibition of meal-stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201-995) in manW E Karnes, V Maxwell, B Sytnik, et al.Alimentary Pharmacology & Therapeutics|September 5, 2014
End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndromeM F Dawwas, G P AithalAlimentary Pharmacology & Therapeutics|September 2, 2014
Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination SurveyH Shen, G Shahzad, M Jawairia, et al.Alimentary Pharmacology & Therapeutics|March 9, 2016
Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseasesA Buisson, E Vazeille, R Minet-Quinard, et al.Alimentary Pharmacology & Therapeutics|March 3, 2016
Helicobacter pylori in children with asthmatic conditions at school age, and their mothersW J den Hollander, A M M Sonnenschein-van der Voort, I L Holster, et al.Alimentary Pharmacology & Therapeutics|April 11, 2016
Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearanceP P Gounder, L R Bulkow, M Snowball, et al.Alimentary Pharmacology & Therapeutics|July 2, 2016
Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver diseaseM Fraquelli, A Baccarin, G Casazza, et al.Alimentary Pharmacology & Therapeutics|November 4, 2015
The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European studyV S Hegade, M Krawczyk, A E Kremer, et al.Alimentary Pharmacology & Therapeutics|October 3, 2015
CorrigendumAlimentary Pharmacology & Therapeutics|November 13, 2015
Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomesA C Cheung, L Lapointe-Shaw, M Kowgier, et al.Pageof 852